Osteoarthritis: Pharmacology and clinical indications of selected botanicals

Pain Clinic

Volumn 16, Issue 1, 2004, Pages 1-16

  Chrubasik, Sigrun ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Devil's claw; Pain; Willow bark

Indexed keywords

6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIINFLAMMATORY AGENT; CALCIMYCIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; DIACETYLRHEIN; DICLOFENAC; DOLOTEFFIN; GLYCOPROTEIN P; HARPAGIDE; HARPAGOPHYTUM EXTRACT; HARPAGOSIDE; HERBACEOUS AGENT; INDOMETACIN; INTERLEUKIN 1BETA; IRIDOID; LEUKOTRIENE; LIPOPOLYSACCHARIDE; LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENYLBUTAZONE; ROFECOXIB; SALICIN; SALIX EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; WS 1531;

ACUPUNCTURE; ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; COST; DOSE RESPONSE; DRUG DOSE; DRUG EFFICACY; DRUG MECHANISM; ELECTROSTIMULATION THERAPY; EXERCISE; EXTRACT; GASTROINTESTINAL SYMPTOM; HARPAGOPHYTUM; HUMAN; HYPERTHERMIC THERAPY; MASSAGE; MUD THERAPY; NERVE BLOCK; NONHUMAN; OSTEOARTHRITIS; PAIN; RELAXATION TRAINING; REVIEW; SKIN MANIFESTATION; SPA TREATMENT; TRANSCUTANEOUS NERVE STIMULATION; WILLOW;

EID: 1542514864     PISSN: 01691112     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856904322858648     Document Type: Review

References (44)

1. Chrubasik S, Junck H, Zappe HA, et al., A survey on pain complaints and health care utilization in a German population sample, Eur J Anaesthesiol 15, 397-408 (1998).
2. Van Tulder MW, Koes BW, Bouter LM, Conservative treatment of acute and chronic nonspecific low back pain, Spine 22, 2128-56 (1997).
3. ESCOP Monograph. Harpagophyti radix, Fascicule 2 (1996) ISBN 1-901964-01-9.
4. Boje K, Phytochemische und biopharmazeutische Untersuchungen an Harpagophytum procumbens DC. Thesis, University of Muenster, 2002.
5. Chrubasik S, Sporer F, Wink M, Zum Wirkstoffgehalt in Arzneimitteln aus Harpagophytum procumbens, Forsch Komplementärmed 3, 57-63 (1996).
6. Mestdagh O, Torck M, Etudes de la qualite de gelules de Harpagophyton, Ann Pharmaceutiques francaises 53, 135-7 (1995).
7. Chrubasik S, Sporer F, Wink M, Zum Wirkstoffgehalt in Teezubereitungen aus Harpagophytum procumbens, Forsch Komplementärmed 3, 116-9 (1996).
8. Chrubasik S, Junck H, Breitschwerdt H, et al., Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: a randomized placebo-controlled double-blind study, Eur J Anaesthesiol 16, 118-29 (1999).
9. Sporer F, Chrubasik S, Präparate aus der Teufelskralle (Harpagophytum procumbens), Zschr Phytotherapie 20, 235-6 (1999).
10. Chantre P, Cappelaere A, Leblan D, et al., Efficacy and tolerability of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis, Phytomedicine 7, 177-83 (2000).
11. Chrubasik S, Sporer F, Dillmann-Marschner R, et al., Physikalisch-chemische Eigenschaften von Harpagosid und in-vitro-Freisetzung von Harpagosid aus Harpagophytum-Tabletten, Phytomedicine 6, 469-73 (2000).
12. Loew D, Mollerfeld J, Schrodter A, et al., Investigation on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo, Clin Pharmacol Ther 69, 356-64 (2001).
13. Fiebich BL, Heinrich M, Hiller K-O, et al., Inhibition of TNFα synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69, Phytomedicine 8, 28-30 (2001).
14. Chrubasik S, Fiebich B, Black A, et al., Treating low back pain with an extract of Harpagophytum that inhibits cytokine release, Eur J Anaesthesiol 10, 209 (2002).
15. Lanhers MC, Fleurentin J, Mortier F, et al., Anti-inflammatory and analgesic effects of an aquous extract of Harpagophytum procumbens, Planta Medica 58, 117-23 (1992).
16. Soulimani R, Younos C, Mortier F, et al., The role of stomachal digestion on the pharmacological activity of plant extracts, using as an example extracts of Harpagophytum procumbens, Can J Physiol Pharmacol 72, 1532-6 (1994).
17. Eichler O, Koch C, Über die antiphlogistische, analgetische und spasmolytische Wirksamkeit von Harpagosid, einem Glykosid aus der Wurzel von Harpagophytum procumbens D, Arzneimittel-Forsch/Drug Res 20, 107-9 (1970).
18. Erdös A, Fontaine R, Friehe H, et al., Beitrag zur Pharmakologie und Toxikologie verschiedener Extrakte, sowie des Harpagosids aus Harpagophytum procumbens DC, Planta Medica 34, 97-108 (1978).
19. Baghdikian B, Lanhers MC, Fleurentin J, et al., An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri, Planta Medica 63, 171-6 (1997).
20. Chrubasik S, Wink M, Zur pharmakologischen Wirkung der Teufelskralle (Harpagophytum procumbens), Forsch Komplementärmed 2, 323-5 (1995).
21. Chrubasik S, Conradt C, Black A, The quality of clinical trials with Harpagophytum procumbens, Phytomedicine 10, 613-23 (2003).
22. Chrubasik S, Zimpfer Ch, Schütt U, et al., Effectiveness of Harpagophytum procumbens in treatement of acute low back pain, Phytomedicine 3, 1-10 (1996).
23. Chrubasik S, Model A, Pollak S, et al., A randomised double-blind pilot study comparing Doloteffin and Vioxx in the treatment of low back pain, Rheumatology 42, 141-8 (2003).
24. Chrubasik S, Thanner J, Künzel O, et al., Comparison of outcome measures during treatment with the proprietary Harpagophytum extract Doloteffin® in patients with pain in the lower back, knee or hip, Phytomedicine 9, 181-94 (2002).
25. ESCOP Monograph. Salicis Cortex (Willow Bark), Fascicule 4 (1997) ISBN 1-90196403-5.
26. Steinegger E, Hövel A, Analytische und biologische Untersuchungen an Saliceen-Wirkstoffen, insbesondere an Salicin. II. Biologische Untersuchungen, Pharm Acta Helv 47, 222-34 (1972).
27. Schmid BM, Behandlung von Cox- und Gonarthrosen mit einem Trockenextrakt aus Salix purpurea and daphnoides, Thesis, University of Tübingen (1998).
28. Fiebich B, Chrubasik S, Effects of an ethanolic Salix extract on the release of selected inflammatory mediators in vitro, Phytomedicine (2003) (in press).
29. Chrubasik S, Pollak S, Wirksamkeit von Weidenrindenextrakt bei Schmerzen, Zschr Phytotherapie 23, 263-66 (2002).
30. Leslie GB, A pharmacometric evaluation of nine Bio-Strath Herbal Remedies, Medica 10, 31-47 (1978).
31. Glinko A, Pharmacological properties of a standardized extract from Willow bark (Cortex salicis), Thesis, Pomeranian Academy of Medicine, Szczecin, Poland (1998).
32. Lewis DA, Shaw GP, A natural flavonoid and synthetic analogues protect the gastric mucosa from aspirin-induced erosions, J Nutr Biochemistry 12, 95-100 (2001).
33. Chrubasik S, Eisenberg E, Balan E, et al., Treatment of low back pain exacerbations with willow bark extrakt: a randomised double-blind study, Am J Med 109, 9-14 (2000).
34. Krivoy N, Pavlotzky E, Chrubasik S, et al., Effect of Salicis Cortex extract on human platelet aggregation, Planta Medica 67, 209-13 (2001).
35. Chrubasik S, Künzel O, Acker A, et al., Preliminary data on the effectiveness, safety and treatment cost of a willow bark special extract in outpatient treatment of low back pain: an open controlled study, Phytomedicine 8, 241-51 (2001).
36. Chrubasik S, Künzel O, Model A, et al., Treatment of low back pain with a herbal or synthetic antirheumatic: a randomized controlled study, Rheumatology 40, 1388-93 (2001).
37. ESCOP Monograph. Urticae folium/herba and Ribis nigri folium, Fascicule 4 (1997) ISBN 1-901964-03-5.
38. Kimmatkar N, Thawani V, Hingorani L, et al., Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee - A randomized double-blind placebo controlled trial, Phytomedicine 10, 3-7 (2003).
39. Bliddal H, Rosetzky A, Schlichting P, A randomised, placebo-controlled, cross-over study of ginger extracts and Ibuprofen in osteoarthritis, Osteoarthritis Cartilage 8, 9-12 (2000).
40. Altman RD, Marcussen KC, Effects of a ginger extract on knee pain in patients with osteoarthritis, Arthritis Rheum 44, 2531-38 (2001).
41. Maheu E, Mazieres B, Valat JP, et al., Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip. A prospective, randomized, double-blind study, placebo-controlled, multicenter clinical trial with six months treatment period and a two-month follow-up demonstrating persistent effect, Arthritis Rheum 41, 81-91 (1998).
42. Blotman F, Maheu E, Wulwik A, et al., Efficacite et tolerance des insaponifiables d'avocat/soja dans le traitement de la gonarthrose et de la coxarthrose symptomatiques. Essai prospectif, multicentrique, de trois mois, randomise, en double insu, contrôle versus placebo, Rev Rhum Mal Osteoartic 41, 81-91 (1997).
43. Appelboom T, Schuermans J, Verbruggen G, et al., Symptoms modyfying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis, Scand J Rheumatol 30, 242-7 (2001).
44. Lequesne M, Maheu E, Cadet C, et al., Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip, Arthritis Rheum 47, 50-8 (2002).